Tenaya Therapeutics share price logo

Tenaya Therapeutics

NASDAQ: TNYA

$0.66

(+0.15%)

as on

Tenaya Therapeutics Stock Performance

as on September 10, 2026 at 6:59 am IST

  • Day's High

    $0.66
    $0.69

    4.55%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $0.53
    $2.35
    downward going graph

    19.45%

    Downside

    256.06%

    Upside

    downward going graph

Tenaya Therapeutics share price movements today

Previous Close
$0.66
Open
$0.68
Volume
1.3M
Market Cap
$153.2M
Day's Low - High
$0.66 - $0.69
52 Week Low - High
$0.53 - $2.35

Tenaya Therapeutics Historical Returns

1 Month Return
-8.72 %
3 Month Return
-6.56 %
1 Year Return
-48.97 %
3 Year Return
-78.6 %
5 Year Return
-97.32 %

Tenaya Therapeutics Stock Fundamentals & Key Indicators

Check Tenaya Therapeutics market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$153.2M

EPS (TTM)

-0.53

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-1.25

Industry PE ratio

-1.62

PEG Ratio

-0.02274040695176033

EBITDA

-96.0M

Revenue (TTM)

1.3M

Profit Margin

263.67%

Return On Equity TTM

-108.05%

Tenaya Therapeutics Stock Valuation

Track how Tenaya Therapeutics P/E has moved over time to understand its valuation trends.

Tenaya Therapeutics in the last 5 years

  • Overview

  • Trends

Lowest (-10.76x)

December 31, 2021

Industry (-1.62x)

December 31, 2025

Today (-1.21x)

December 31, 2025

Highest (-0.73x)

December 31, 2022

LowHigh

Today’s Price to Earnings Ratio: -1.21x

Tenaya Therapeutics vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Tenaya Therapeutics with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
BUY$153.2M-97.32%-1.25263.67%NA
BUY$44.6B614.61%NA0.00%NA
BUY$138.4B181.2%30.5486.04%NA
BUY$58.1B-69.22%-17.59-12.57%NA
BUY$85.2B25.41%19.3584.86%0.45999999999999996%

Stock Returns calculator for Tenaya Therapeutics Stock including INR - Dollar returns

The Tenaya Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

Tenaya Therapeutics investment value today

Current value as on today

₹54,714

Returns

-₹45,286

(-45.29%)

Returns from Tenaya Therapeutics Stock

-₹49,231 (-49.23%)

Dollar Impact

₹3,945 (+3.94%)

Analyst Recommendation on Tenaya Therapeutics Stock

Based on 5 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 5 analysts, 100% of analysts recommend a 'BUY' rating for Tenaya Therapeutics. Average target price of $3.2

Tenaya Therapeutics Share Price Target

Get share price movements and forecasts by analysts on Tenaya Therapeutics.

What analysts predicted

79.38%UPSIDE

Target Price

$3.2

Current Price

$0.66

Analyzed by

5 Analysts

Target

$3.20

Tenaya Therapeutics target price $3.2, a slight upside of 79.38% compared to current price of $0.66. According to 5 analysts rating.

Indian Investors' Interest in Tenaya Therapeutics Stock

Search interest for Tenaya Therapeutics Stock has decreased by -11% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-11% versus previous 30 day period

Tenaya Therapeutics Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
-
-
-
-
-
-
-
-
0
1
Gross Profit
-2
-2
-
-
-
-2
-
3
-1
1
Operating Income
-33
-30
-26
-24
-27
-24
-20
-20
-20
-44
EBITDA
-30
-27
-23
-21
-24
-21
-18
-18
-17
-41
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
2
2
2
2
2
2
1
1
1
1
Income Before Tax
-32
-29
-25
-23
-26
-23
-20
-20
-19
-43
Income Tax Expense
-
-
-
-
-
-
-
-
-
-
Net Income
-32
-29
-25
-23
-26
-23
-20
-20
-19
-43
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
-683.56%
100.00%

Tenaya Therapeutics Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
-
-
-
-
-
-
-
Gross Profit
-1
-2
-4
-8
-8
-8
-8
Operating Income
-27
-38
-72
-125
-131
-115
-93
EBITDA
-25
-35
-68
-114
-115
-102
-82
Interest Expense
-
-
-
-
-
-
-
Depreciation
1
2
4
8
8
8
8
Income Before Tax
-26
-38
-72
-123
-124
-111
-90
Income Tax Expense
-
-
-
-
-
-
-
Net Income
-25
-38
-72
-123
-124
-111
-90
Net Profit Margin
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%

Tenaya Therapeutics Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-32
-29
-25
-23
-26
-23
-20
-20
-19
-62
Operating Cash Flow
-28
-23
-19
-18
-23
-15
-15
-13
-19
-22
Investing Cash Flow
-4
21
-30
14
22
24
8
0
0
0
Financing Cash Flow
46
0
0
0
50
0
0
58
0
0
Change in Cash
13
-1
-49
-3
49
8
-6
44
-19
-22

Tenaya Therapeutics Annual Cash Flow

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-26
-38
-72
-123
-124
-111
-90
Operating Cash Flow
-24
-35
-60
-104
-102
-90
-68
Investing Cash Flow
-5
-7
-238
83
48
1
56
Financing Cash Flow
30
147
208
77
4
47
108
Change in Cash
0
104
-90
56
-49
-41
96

Mutual Funds that own Tenaya Therapeutics Stock

Check out the Mutual Funds with significant holdings in Tenaya Therapeutics.

Funds
Holdings
Shares Held
VANGUARD INDEX FUNDS
3.679558%
8250674
Fidelity Concord Street Trust
0.444108%
995825
Bridgeway Funds, Inc.
0.078044%
175000
TIAA-CREF Funds
0.05903%
132365
VANGUARD VALLEY FORGE FUNDS
0.052794%
118382

Global Institutional Holdings in Tenaya Therapeutics

Funds
Holdings
Vanguard
3.08%
Bruce Winson
1.85%
iShares
0.87%
Invesco
0.16%
Kenneth Tropin
0.08%

Insights on Tenaya Therapeutics

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 473.5% return, outperforming this stock by 522.5%

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 30.4% return, outperforming this stock by 109.0%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 7 days, TNYA stock has moved down by -5.1%

About Tenaya Therapeutics

Tenaya Therapeutics, Inc., a clinical-stage biotechnology company, discovers, develops, and delivers therapies for heart disease in the United States. Its lead product candidate includes TN-201, a gene therapy for myosin binding protein C3-associated hypertrophic cardiomyopathy that is in Phase 1b/2 clinical trial; TN-401, a gene therapy for plakophilin 2-associated arrhythmogenic right ventricular cardiomyopathy, which is in Phase 1b/2 clinical trial; and TN-301, a small molecule histone deacetylase-6 for heart failure with preserved ejection fraction that is in phase 1 clinical trial. The company develops its products through gene addition, gene editing, gene silencing, and cellular regeneration. It has a research collaboration agreement with Alnylam Pharmaceuticals, Inc. to identify and validate novel gene targets for the potential treatment of cardiovascular disease. Tenaya Therapeutics, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.
OrganisationTenaya Therapeutics
Headquarters171 Oyster Point Boulevard, South San Francisco, CA, United States, 94080
IndustryBiotechnology
CEOMr. Faraz Ali M.B.A.
E-voting on sharesClick here to vote

Key Management of Tenaya Therapeutics

Name

Title

Dr. Whittemore G. Tingley M.D., PH.D.

Chief Medical Officer

Dr. Bruce R. Conklin M.D.

Scientific Founder

Dr. Sheng Ding Ph.D.

Scientific Founder

Dr. Benoit G. Bruneau Ph.D.

Scientific Founder

Dr. Kee-Hong Kim Ph.D.

Chief Technology Officer

Dr. Deepak Srivastava M.D.

Scientific Founder, Chairman of Scientific Advisory Board & Director

Dr. Eric N. Olson Ph.D.

Scientific Founder & Member of Scientific Advisory Board

Dr. Saptarsi Haldar M.D.

Scientific Founder

Mr. Eric Hyllengren

CFO & Principal Accounting Officer

Mr. Faraz Ali M.B.A.

President, CEO & Director

FAQs

What is Tenaya Therapeutics share price today?

Tenaya Therapeutics share price today is $0.66 as on at the close of the market. Tenaya Therapeutics share today touched a day high of $0.69 and a low of $0.66.

What is the 52 week high and 52 week low for Tenaya Therapeutics share?

Tenaya Therapeutics share touched a 52 week high of $2.35 on and a 52 week low of $0.53 on . Tenaya Therapeutics stock price today i.e. is closed at $0.66,which is 71.91% down from its 52 week high and 24.15% up from its 52 week low.

What is Tenaya Therapeutics's market capitalisation today?

Tenaya Therapeutics market capitalisation is $0.00T as on .

How to invest in Tenaya Therapeutics Stock (TNYA) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Tenaya Therapeutics on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Tenaya Therapeutics Shares that will get you 2.2727 shares as per Tenaya Therapeutics share price of $0.66 per share as on September 10, 2026 at 1:29 am IST.

What is the minimum amount required to buy Tenaya Therapeutics Stock (TNYA) from India?

Indian investors can start investing in Tenaya Therapeutics (TNYA) shares with as little as ₹95.105 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹951.05 in Tenaya Therapeutics stock (as per the Rupee-Dollar exchange rate as on ). Based on Tenaya Therapeutics share’s latest price of $0.66 as on September 10, 2026 at 1:29 am IST, you will get 15.1515 shares of Tenaya Therapeutics. Learn more about fractional shares .

What are the returns that Tenaya Therapeutics has given to Indian investors in the last 5 years?

Tenaya Therapeutics stock has given -97.32% share price returns and 28.48% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?